Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Reexamination ...heheeee
Reply New Message
Back To Forum List View
Reexamination ...
3
ease2002
Dec 20, 2009 01:07AM
Re: Reexamination ... "Intervening Rights"

ease2002
Dec 20, 2009 01:23AM
Re: Reexamination..PTO has been granting roughly 97% of the requests it receives
7
Mark4321
Dec 20, 2009 07:36AM
Re: Reexamination..PTO has been granting roughly 97% of the requests it receives
1
ease2002
Dec 20, 2009 12:34PM
Re: Reexamination ...
15
optymystic
Dec 20, 2009 12:49PM
Re: Reexamination..PTO has been granting roughly 97% of the requests it receives

hotflame
Dec 20, 2009 12:55PM
Re: Reexamination../ease... for the record
3
eggbert
Dec 20, 2009 01:04PM
Re: Reexamination ...
1
ease2002
Dec 20, 2009 01:58PM
Re: Reexamination ...FWIW
5
eggbert
Dec 20, 2009 02:19PM
Re: Reexamination ...
2
optymystic
Dec 20, 2009 04:19PM
Re: Reexamination..PTO has been granting roughly 97% of the requests it receives
3
Mark4321
Dec 20, 2009 05:10PM
Icon president Re: Reexamination.. - Mark
5
SGE1
Dec 20, 2009 05:57PM
Re: Reexamination..PTO has been granting roughly 97% of the requests it receives

ease2002
Dec 20, 2009 08:24PM
Re: Reexamination.. - Mark
8
optymystic
Dec 20, 2009 09:24PM
Icon president Reexamination ...heheeee
4
fs2006
Dec 21, 2009 11:01AM
Icon president Re: Reexamination.. - Mark

SGE1
Dec 21, 2009 11:36AM
Re: Reexamination.. -SGE
2
CenturyCom
Dec 21, 2009 01:07PM

Alrighty then, I'm looking forward to next week HUGELY!! Till then I'll be mostly enjoying a holiday!

reply to FS2006 post of a wee while ago......

The agreements come on the heels of a string of successes in the reexamination of the MMP Portfolio™ patents by the USPTO and German Patent Court. In the past 9 months, the German Patent Court affirmed the validity of EP’730, and the USPTO has affirmed the validity of both US’584 and most recently US’336.

http://www.alliacense.com/Press_Release_Details.aspx?PressID=117

5 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply